questionsmedicales.fr
Environnement et santé publique
Santé publique
Facteurs épidémiologiques
Facteurs épidémiologiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs épidémiologiques : Questions médicales les plus fréquentes",
"headline": "Facteurs épidémiologiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs épidémiologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-10",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Santé publique",
"url": "https://questionsmedicales.fr/mesh/D011634",
"about": {
"@type": "MedicalCondition",
"name": "Santé publique",
"code": {
"@type": "MedicalCode",
"code": "D011634",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs âges",
"alternateName": "Age Factors",
"url": "https://questionsmedicales.fr/mesh/D000367",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs âges",
"code": {
"@type": "MedicalCode",
"code": "D000367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Âge de début",
"alternateName": "Age of Onset",
"url": "https://questionsmedicales.fr/mesh/D017668",
"about": {
"@type": "MedicalCondition",
"name": "Âge de début",
"code": {
"@type": "MedicalCode",
"code": "D017668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Âge maternel",
"alternateName": "Maternal Age",
"url": "https://questionsmedicales.fr/mesh/D008423",
"about": {
"@type": "MedicalCondition",
"name": "Âge maternel",
"code": {
"@type": "MedicalCode",
"code": "D008423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Biais (épidémiologie)",
"alternateName": "Bias",
"url": "https://questionsmedicales.fr/mesh/D015982",
"about": {
"@type": "MedicalCondition",
"name": "Biais (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Biais de l'observateur",
"alternateName": "Observer Variation",
"url": "https://questionsmedicales.fr/mesh/D015588",
"about": {
"@type": "MedicalCondition",
"name": "Biais de l'observateur",
"code": {
"@type": "MedicalCode",
"code": "D015588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Biais de sélection",
"alternateName": "Selection Bias",
"url": "https://questionsmedicales.fr/mesh/D015983",
"about": {
"@type": "MedicalCondition",
"name": "Biais de sélection",
"code": {
"@type": "MedicalCode",
"code": "D015983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Causalité",
"alternateName": "Causality",
"url": "https://questionsmedicales.fr/mesh/D015984",
"about": {
"@type": "MedicalCondition",
"name": "Causalité",
"code": {
"@type": "MedicalCode",
"code": "D015984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs précipitants",
"alternateName": "Precipitating Factors",
"url": "https://questionsmedicales.fr/mesh/D015985",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs précipitants",
"code": {
"@type": "MedicalCode",
"code": "D015985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Comorbidité",
"alternateName": "Comorbidity",
"url": "https://questionsmedicales.fr/mesh/D015897",
"about": {
"@type": "MedicalCondition",
"name": "Comorbidité",
"code": {
"@type": "MedicalCode",
"code": "D015897",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Multimorbidité",
"alternateName": "Multimorbidity",
"url": "https://questionsmedicales.fr/mesh/D000076322",
"about": {
"@type": "MedicalCondition",
"name": "Multimorbidité",
"code": {
"@type": "MedicalCode",
"code": "D000076322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de confusion (épidémiologie)",
"alternateName": "Confounding Factors, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015986",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de confusion (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015986",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.718"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modificateur d'effet épidémiologique",
"alternateName": "Effect Modifier, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015987",
"about": {
"@type": "MedicalCondition",
"name": "Modificateur d'effet épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015987",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet de cohorte",
"alternateName": "Cohort Effect",
"url": "https://questionsmedicales.fr/mesh/D015988",
"about": {
"@type": "MedicalCondition",
"name": "Effet de cohorte",
"code": {
"@type": "MedicalCode",
"code": "D015988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet du travailleur en bonne santé",
"alternateName": "Healthy Worker Effect",
"url": "https://questionsmedicales.fr/mesh/D015989",
"about": {
"@type": "MedicalCondition",
"name": "Effet du travailleur en bonne santé",
"code": {
"@type": "MedicalCode",
"code": "D015989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet placebo",
"alternateName": "Placebo Effect",
"url": "https://questionsmedicales.fr/mesh/D015990",
"about": {
"@type": "MedicalCondition",
"name": "Effet placebo",
"code": {
"@type": "MedicalCode",
"code": "D015990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antécédents gynécologiques et obstétricaux",
"alternateName": "Reproductive History",
"url": "https://questionsmedicales.fr/mesh/D017584",
"about": {
"@type": "MedicalCondition",
"name": "Antécédents gynécologiques et obstétricaux",
"code": {
"@type": "MedicalCode",
"code": "D017584",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gravidité",
"alternateName": "Gravidity",
"url": "https://questionsmedicales.fr/mesh/D020073",
"about": {
"@type": "MedicalCondition",
"name": "Gravidité",
"code": {
"@type": "MedicalCode",
"code": "D020073",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Parité",
"alternateName": "Parity",
"url": "https://questionsmedicales.fr/mesh/D010298",
"about": {
"@type": "MedicalCondition",
"name": "Parité",
"code": {
"@type": "MedicalCode",
"code": "D010298",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Intervalle sériel de l'infection",
"alternateName": "Serial Infection Interval",
"url": "https://questionsmedicales.fr/mesh/D000088822",
"about": {
"@type": "MedicalCondition",
"name": "Intervalle sériel de l'infection",
"code": {
"@type": "MedicalCode",
"code": "D000088822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteurs sexuels",
"alternateName": "Sex Factors",
"url": "https://questionsmedicales.fr/mesh/D012737",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs sexuels",
"code": {
"@type": "MedicalCode",
"code": "D012737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndémique",
"alternateName": "Syndemic",
"url": "https://questionsmedicales.fr/mesh/D000076603",
"about": {
"@type": "MedicalCondition",
"name": "Syndémique",
"code": {
"@type": "MedicalCode",
"code": "D000076603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques",
"alternateName": "Epidemiologic Factors",
"code": {
"@type": "MedicalCode",
"code": "D015981",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J X Chen",
"url": "https://questionsmedicales.fr/author/J%20X%20Chen",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "L G Tian",
"url": "https://questionsmedicales.fr/author/L%20G%20Tian",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "Rong Zhang",
"url": "https://questionsmedicales.fr/author/Rong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Yanyan Hu",
"url": "https://questionsmedicales.fr/author/Yanyan%20Hu",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Hongwei Zhou",
"url": "https://questionsmedicales.fr/author/Hongwei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36599813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ejh.13925"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36454598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13387"
}
},
{
"@type": "ScholarlyArticle",
"name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.",
"datePublished": "2024-02-01",
"url": "https://questionsmedicales.fr/article/38299721",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17739"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36758527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000529542"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.",
"datePublished": "2022-11-12",
"url": "https://questionsmedicales.fr/article/36369934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17184"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D015981"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs épidémiologiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs épidémiologiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs épidémiologiques",
"description": "Comment évaluer les facteurs épidémiologiques d'une maladie ?\nQuels outils sont utilisés pour le diagnostic épidémiologique ?\nQuelle est l'importance des études de cohorte ?\nComment les facteurs environnementaux sont-ils diagnostiqués ?\nQuel rôle joue la surveillance épidémiologique ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs épidémiologiques",
"description": "Quels symptômes peuvent indiquer une épidémie ?\nComment les symptômes varient-ils selon les populations ?\nQuels symptômes sont liés aux maladies infectieuses ?\nLes symptômes peuvent-ils être influencés par des facteurs socio-économiques ?\nComment les symptômes psychologiques sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs épidémiologiques",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment les facteurs épidémiologiques influencent-ils la prévention ?\nQuel rôle joue la sensibilisation dans la prévention ?\nComment les politiques de santé publique influencent-elles la prévention ?\nLes programmes de dépistage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs épidémiologiques",
"description": "Quels traitements sont influencés par des facteurs épidémiologiques ?\nComment les traitements sont-ils adaptés aux épidémies ?\nQuel est l'impact des traitements préventifs ?\nComment évaluer l'efficacité des traitements ?\nLes traitements varient-ils selon les régions géographiques ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs épidémiologiques",
"description": "Quelles complications peuvent survenir lors d'épidémies ?\nComment les complications affectent-elles la santé publique ?\nLes complications varient-elles selon les groupes d'âge ?\nQuel est l'impact des complications sur la qualité de vie ?\nComment prévenir les complications liées aux maladies ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs épidémiologiques",
"description": "Quels sont les principaux facteurs de risque épidémiologiques ?\nComment les facteurs environnementaux influencent-ils les risques ?\nLes antécédents familiaux sont-ils des facteurs de risque ?\nQuel rôle joue le mode de vie dans les facteurs de risque ?\nComment les facteurs de risque sont-ils identifiés ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les facteurs épidémiologiques d'une maladie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des études épidémiologiques et des analyses statistiques."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic épidémiologique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enquêtes, les registres de santé et les bases de données sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des études de cohorte ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'observer l'incidence des maladies sur des groupes spécifiques dans le temps."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux sont-ils diagnostiqués ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études de cas-témoins et des analyses de l'exposition environnementale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la surveillance épidémiologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de détecter et de suivre les tendances des maladies dans la population."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une épidémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation soudaine de cas similaires dans une population peut être un indicateur."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les populations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la génétique, de l'environnement et des comportements."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux maladies infectieuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires sont souvent associés aux infections."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être influencés par des facteurs socio-économiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions socio-économiques peuvent affecter l'accès aux soins et la santé globale."
}
},
{
"@type": "Question",
"name": "Comment les symptômes psychologiques sont-ils pris en compte ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent évalués dans le cadre d'études sur la santé mentale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination et l'éducation à la santé sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment les facteurs épidémiologiques influencent-ils la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier les populations à risque et à cibler les interventions préventives."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la sensibilisation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation augmente la connaissance des risques et encourage des comportements sains."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé publique influencent-elles la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles établissent des directives et des ressources pour réduire les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les programmes de dépistage sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter précocement les maladies et d'améliorer les résultats de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont influencés par des facteurs épidémiologiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent varier selon la prévalence des maladies dans une population donnée."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils adaptés aux épidémies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont ajustés en fonction des caractéristiques de la maladie et des populations touchées."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements préventifs réduisent l'incidence des maladies dans les populations à risque."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des essais cliniques et des études de suivi sur les résultats de santé."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les régions géographiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des ressources et des besoins locaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors d'épidémies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la surcharge des systèmes de santé et l'augmentation de la mortalité."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la santé publique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des coûts élevés et des défis pour la gestion des soins de santé."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les groupes d'âge ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes et les personnes âgées peuvent avoir des complications différentes."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie et augmenter le besoin de soins."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des interventions précoces et un suivi régulier des patients à risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque épidémiologiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe, le statut socio-économique et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux influencent-ils les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, le climat et l'accès aux soins peuvent augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils des facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent prédisposer à certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils identifiés ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques et des analyses de données de santé publique."
}
}
]
}
]
}
The delayed platelet engraftment associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a common complication and often results in increased transplant-related complications...
Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based...
A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d...
We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape...
An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...
Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u...
Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a...
The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t...
Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...
The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ...
Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be...
A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign...
To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....
Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10...
Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible...
Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans...
Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....
Platelet transfusion refractoriness due to HLA alloimmunization presents a significant medical problem, particularly among multiply transfused patients with hematologic malignancies and those undergoi...
Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia...
Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group....
43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland....
660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10...
Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10...
Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea...
Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c...
Infants randomised to a higher platelet transfusion threshold of 50×10...
ISRCTN87736839....
Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t...
In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au...
All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and...
In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...
The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for...
We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto...
A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over...
During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....
We report Listeria monocytogenes infection in a patient in Italy who was transfused with pooled platelet concentrate. Genomic analysis revealed that L. monocytogenes isolates from the donor blood unit...